BALAXI PHARMACEUTICALS LIMITED — Others, 11-02-2025: Copy of Newspaper Publication

Balaxi Pharmaceuticals has announced a board meeting to discuss the financial results for the quarter ended December 31, 2024. The company reported total income from operations of ₹1,115.83 crore, with a net profit after tax of ₹174.32 crore. Their comprehensive income stood at ₹174.32 crore, reflecting a solid recovery compared to the same quarter last year. Moreover, net worth has increased to ₹34,584.80 crore.

This positive financial performance may enhance investor sentiment, showcasing potential growth opportunities and financial resilience. Investors should watch for how this trend impacts share performance and company strategy moving forward.